SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001078782-20-000007
Filing Date
2020-01-08
Accepted
2020-01-08 14:26:21
Documents
9
Period of Report
2020-01-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8K CURRENT REPORT f8k010820_8k.htm 8-K 17036
2 EXHIBIT 10.1 BINDING TERM SHEET DATED JANUARY 3, 2020, BY AND BETWEEN AXIM BIOTE f8k010820_ex10z1.htm EX-10.1 2272
3 EXHIBIT 99.1 PRESS RELEASE f8k010820_ex99z1.htm EX-99.1 12420
4 IMAGE f8k0108208k1.jpg GRAPHIC 28546
5 IMAGE f8k010820ex10z11.jpg GRAPHIC 466927
6 IMAGE f8k010820ex10z12.jpg GRAPHIC 474434
7 IMAGE f8k010820ex10z13.jpg GRAPHIC 144948
8 IMAGE f8k010820ex10z14.jpg GRAPHIC 123920
9 IMAGE f8k010820ex10z15.jpg GRAPHIC 98193
  Complete submission text file 0001078782-20-000007.txt   1874229
Mailing Address 45 ROCKEFELLER PLAZA 20TH FLOOR, STE 83 NEW YORK NY 10022
Business Address 45 ROCKEFELLER PLAZA 20TH FLOOR, STE 83 NEW YORK NY 10022 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54296 | Film No.: 20515346
SIC: 2834 Pharmaceutical Preparations